Hope for kids with Tough-to-Treat IBD: study tests Next-Generation drugs
NCT ID NCT07198113
Summary
This study aims to find out which newer medications work best and are safest for children with inflammatory bowel disease (IBD) when standard anti-TNF drugs have stopped working. It will follow about 1100 children and teens who are already starting one of these newer medications as part of their regular care. Researchers will track their symptoms, quality of life, and any side effects over up to three years to compare the different treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Health System
Durham, North Carolina, 27701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.